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ABSTRACT 
Zika virus (ZIKV) is an aedes mosquito borne pathogen belonging to the member of 
flaviviridae subgroup is the causative agent of an emerging disease called Zika fever, known 
as a benign infection usually presenting as influenza like illness with cutaneous rash. Due to 
recent epidemic outbreaks it is realized as a major health risk which need enhanced 
surveillance, but no attempt has been made to design an epitope based peptide vaccine against 
Zika virus. Viral envelope proteins are derived from host cell membrane proteins with some 
viral glycoproteins and are used to cover their protective protein capsid, help the viruses to 
enter host cells and help them to avoid the host immune response. In this study, amino acid 
sequence of ZIKV envelope glycoprotein was obtained from a protein database and examined 
with in silico approaches to determine the most immunogenic epitopes for B cell and T cell 
which could induce humoral as well as cell mediated immune response. Both the linear and 
conformational epitopes for B cell were predicted by immunoinformatics tools housed in 
IEDB resources. The peptide sequence DAHAKRQTVVVLGSQEGAV from position 121 
and peptide sequence from 117-137 amino acids were predicted as most potential B cell linear 
and conformational epitopes respectively. Epitopes for CD4+ and CD8+ T cell were also 
predicted by using tools within IEDB resource and peptide sequence MMLELDPPF from 
position 250-258 amino acids was predicted as most immunogenic CD8+ T cell epitope with 
immune response evoking ability prediction score (I pMHC) of 0.09139 and conservancy of 
52.17%. The innate immune response for ZIKV envelope glycoprotein was determined by 
interferon (IFN)-gamma effectuation and mimicking capacity by immunoinformatics and 
molecular docking study respectively. However, this is an introductory approach to design an 
epitope based peptide vaccine against Zika virus; we hope this model will be very much 
helpful in designing and predicting novel vaccine candidate. 
Introduction 
Zika virus (ZIKV) a group IV, positive sense single stranded 
RNA (11 kilobases) arbovirus of Flavivirus genus belonging 
to Flaviviridae family is related to yellow fever, dengue, West 
Nile, St. Louis encephalitis and Japanese encephalitis viruses 
causing dengue fever like syndrome including  mild headache, 
maculopapular rash, fever, malaise, conjunctivitis, and 
arthralgia [1,2]. Nowadays a lot of research efforts have 
enlightened on many of these viruses but other members of the 
mosquito borne flaviviruses, such as ZIKV, have received far 
less attention. In 1947 the virus was first isolated from a 
febrile sentinel rhesus monkey (Rhesus 766) placed in a cage 
in the Zika forest of Uganda under the observation of 
Rockefeller Foundation’s program for research on jungle 
yellow fever [2] while a second isolation was done from the 
mosquito Aedes africanus followed at the same site in January 
1948 [1]. Most likely it is thought that, ZIKV maintained a 
sylvatic cycle involving non-human primates and several 
Aedes species (Ae.africanus, Ae.aegypti and others) as 
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mosquito vectors [2-4], with cyclic epizootics in monkeys 
reported in Uganda [5-8]. Humans are get infected by 
infective mosquito bites, however recent report suggests that 
there is a possibility of secondary sexual transmission [9]. 
ZIKV is endemic in Africa and south-east Asia [2] and 
phylogenetic analysis revealed that African and Asian strains 
emerged as two distinct lineages [10-11]. In 2007, ZIKV has 
caused a large epidemic on Yap Island, Federated States of 
Micronesia and involved in infecting three quarter of local 
populations [12]. This outbreak shows that, ZIKV has been 
detected outside of Africa and Asia, having the potential as an 
emerging pathogen [9]. The viral illness (Zika fever) is an 
emerging disease due to the expanding distribution area of 
ZIKV, confirmed by the recent epidemic affecting French 
Polynesia, New Caledonian since October 2013 [10] and Cook 
Island in march, 2014.  
Zika virus genome contains 59 and 39 untranslated regions 
flanking a single open reading frame (ORF) that encodes a 
polyprotein that is cleaved into three structural proteins: the 
capsid (C), premembrane/membrane (prM), and envelope (E); 
and seven non-structural proteins (NS1, NS2A, NS2B, NS3, 
NS4A, 2K, NS4B, and NS5) [13]. The 5′ end of positive-
strand genomic RNA is modified with a cap-1 structure (me7-
GpppA-me2) formed by an RNA triphosphatase, with 
guanylyltransferase, N7-methyltransferase and 2′-O 
methyltransferase. The non structural proteins are responsible 
for these activities. The NS3 protein encodes a RNA 
triphosphatase within its helicase domain. The N-terminal 
domain of the non-structural protein 5 (NS5) has both the N7-
methyltransferase and guanylyltransferase activities necessary 
for forming mature RNA cap structures. RNA binding affinity 
is reduced by the presence of ATP or GTP and enhanced by S-
adenosyl methionine [14]. This protein also encodes a 2′-O 
methyltransferase. 
Currently there is no medicine against Zika fever or specific 
antiviral treatment for clinical ZIKV infection is available. 
Someone protect him/herself by preventing mosquito bites 
[15]. So the development of a new vaccine against ZIKV is 
very much important and this development has not yet been 
achieved. Surface or envelope proteins of virus are most 
antigenic one and often considered as good candidates for 
immunization. It is particularly important for vaccine 
development as it mediates the viral entry and also the primary 
target of adaptive immune response [16, 17]. In vaccine 
development it would be very much helpful if the epitopes 
associated with envelope glycoprotein are well known, and 
that could facilitate their synthetic production along with 
consistent cost and quality advantages over the current 
treatment [18]. Development of immunity against viral 
infection is mediated by a variety of specific and non-specific 
immune mechanisms involves the stimulation of antigen 
specific CD8+ cytotoxic T lymphocytes (CTL) and B cells 
[19]. Induction and development of effective immune 
response highly depends on specific and potent antigen 
presentation by human leukocyte antigen (HLA) class I alleles 
(MHC class I molecule) which present antigenic peptides on 
infected cells to CTLs and class II alleles (MHC class II 
molecule) which presents peptide antigen to CD4+ helper T 
(Th) cells and ultimately converge to B cell response [20-22]. 
During viral infection a non-specific immune response is also 
mediated by interferon (IFN) gamma, which increase CD8+ 
cytotoxic T lymphocytes along with the enhancement of MHC 
class I and II dependent antigen presentation [23].  
To design an effective synthetic peptide vaccine candidate, in 
silico modeling and immunoinformatics strategies have been 
exploited which uses a variety of statistical and machine 
learning approaches by the help of bioinformatics software 
and machine learning programs. Such active vaccine candidate 
must have to contain minimum two antigenic epitopes; one to 
induce specific B cell or CTL responses while other induce 
specific Th cell response. This study has important 
implications on computational tools to screen B and T cell 
epitopes as well as to assess the IFN-gamma inducing effect of 
ZIKV envelope glycoprotein, a critical step in the 
development of vaccines.   
Materials and methods 
 
Retrieval of Zika virus envelope glycoprotein sequence 
Zika virus envelope (outer membrane) glycoprotein sequences 
were obtained from UniProtKB (www.uniprot.org/) in FASTA 
format [24].  
 
Protein antigenicity determination 
To predict the protective antigens as vaccines, the sequence 
was then analyzed with VaxiJen [25] with default parameters 
to find out antigenicity. All the antigenic proteins with their 
respective predicted score were then filtered and a single 
antigenic protein with highest antigenicity score was selected 
for further evaluation.   
 
Primary and secondary structure prediction 
A proteomics server, ExPASy ProtParam (www.expasy.org) 
was used to analyze the primary structure of the target protein. 
Several parameters given by ProtParam tool for example 
molecular weight, theoretical pI, amino acid composition, 
atomic composition, extinction coefficient, estimated half-life, 
instability index, aliphatic index and grand average of 
hydropathicity (GRAVY) were examined. The secondary 
structure (alpha helix, beta plated sheets, turns and coils) of 
the protein was checked by using different servers like Jpred3 
[26], GOR IV [27] and SOPMA [28] which aims to predict 
solvent accessibility, transmembrane helices, globular regions, 
and coiled-coil regions and finally determines the protein’s 
stability and function. 
3D structure modeling (homology modeling) and 
validation 
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The sequence homology approach to model 3D structure of a 
protein uses sequence alignment to identify the best matching 
3D structure for different components: conserved portion, loop 
portion and side chains from the database, and threads them to 
predict the overall 3D structure [29]. The crystal or NMR 
structure of Zika virus envelope protein was not available in 
the Protein Data Bank (PDB), so that the sequence of envelope 
protein was used to develop the 3D structure through 
homology modeling.  
For homology modeling we did blastp (protein-protein 
BLAST) by using PDB database and among 67 templates 
chose two with highest hit (template 1: pdb accession 3P54_A 
and template 2: pdb accession 4FG0_A). Then 3D structure of 
the best template for Zika virus envelope glycoprotein was 
generated by using protein structure modeling server SWISS-
MODEL (swissmodel.expasy.org) and HHpred a protein 
function and protein structure prediction server 
(toolkit.tuebingen.mpg.de/hhpred) along with their confidence 
score. After generating the 3D models, structure analysis and 
stereochemical analysis were performed and best 3D model 
was selected by using   evaluation and validation tools 
QMEAN, ProSA, PROCHECK, RAM-PAGE and SAVES 
online tool (http://services.mbi.ucla.edu/SAVES/) [30-34].  
The best 3D model was selected on the basis of QMEAN4 
global scores, Z-score and Ramachandran plot. The QMEAN4 
global score was obtained by using QMEAN server while the 
Ramachandran plot was obtained using PROCHECK and 
RAM-PAGE. Ramachandran plot was very much useful in 
evaluating backbone conformation as well as in checking non-
GLY residues at disallowed regions. The verify 3D and ProSA 
web tool was used to determine Z-scores while ERRAT was 
used to predict overall quality for model and was assured 
using Z-scores [34].The validated structure was subjected to 
energy minimization using KoBaMIN, a knowledge-based 
web server for protein structure refinement [35]. 
 
Potential B cell epitope identification 
 
Continuous (linear) epitope identification  
The B cell epitope is the portion of the antigen which interacts 
with B-lymphocytes. As a result, the B-lymphocyte is 
differentiated into antibody-secreting plasma cell and memory 
cells. In other terms, the objective of the B cell epitope is to 
ultimately stimulate the B cell to synthesize the antibody 
specific for it (primary humoral response) or to convert the 
naive B cell into a memory B cell and make it ready to 
produce specific antibody in later encounters [36]. 
B cell epitope is characterized by both being hydrophilic, 
accessible and in a flexible region of an immunogen [37]. 
Thus, the classical propensity scale methods such as Kolaskar 
and Tongaonkar antigenicty scale [38], Emini surface 
accessibility prediction [39], Parker hydrophilicity prediction 
[40], Karplus and Schulz flexibilty prediction [41], and 
Bepipred linear epitope prediction which uses a combinatorial 
algorithm comprising both hidden markov model and 
propensity scale methods antigenic propensity and thus 
performs significantly better than any of the other methods 
and analysis were done computationally from the IEDB 
(http://www.iedb.org/) analysis resource [42]. In several 
experimental studies, it was found that the antigenic parts of a 
protein belong to the beta turn regions [43]. Therefore, the 
Chou and Fashman beta turn prediction tool [44] was used. 
The results from all these sites were cross-referenced, and 
apparently common findings were taken as the continuous 
(linear) B cell epitopes. 
Discontinuous (Conformational) epitope identification  
Conformational epitope for B cell was predicted by ElliPro 
(http://tools.immuneepitope.org/tools/ElliPro)in IEDB 
analysis resources which implements three algorithm 
performing approximation of the protein shape as an ellipsoid 
[45], calculation of residue protrusion index [46] and 
clustering of neighboring residues based on their PI values. 
 
Potential T-cell epitope identification 
 
 CD8+ T-cell epitopes identification 
Linear peptides as T-cell epitopes for ZIKV envelope 
glycoprotein were identified by using NetCTL 1.2 server 
(http://www.cbs.dtu.dk/services/NetCTL/) at a threshold of 
0.75 to have sensitivity and specificity of 0.80 and 0.970 
respectively [47]. The server expands the MHC class I binding 
predicition to 12 MHC supertypes and integrates prediction of 
peptide MHC class I binding, proteasomal C terminal cleavage 
and TAP transport efficiency using artificial neural network 
(ANN). Combined algorithm of MHC-1 binding, transporter 
of antigenic peptides (TAP) transport efficiency and 
proteasomal cleavage efficiency were used to determine the 
overall scores. On the basis of these overall score, 4 best 
epitopes were selected for further evaluation. 
For the prediction of peptides binding to MHC-1, we used a 
different prediction method at Immune Epitope Database 
(IEDB) and predict IC50 values for peptides binding to 
specific MHC molecules [48]. The stabilized matrix base 
method (SMM) was used to calculate IC50 values of peptide 
binding to MHC-1 molecules. Prior to the prediction, peptide 
length was set to 9 amino acids. The alleles having binding 
affinity IC50 less than 200 nm were chosen for further 
analysis.  
The best four epitopes were then fetched to a web based tool 
T-cell epitope processing prediction at IEDB [49] which 
utilizes proteasomal cleavage /TAP transport/ MHC-1 
combined prediction scores using SMM for each peptide's 
intrinsic potential of being a T cell epitope. MHC-NP; 
prediction of peptides naturally processed by the MHC, 
another tool at IEDB server was used to assess the probability 
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that a given peptide is naturally processed and binds to a given 
MHC molecule [50].  
The conservancy and relative ability of peptide epitope – 
MHC 1 complex to elicit an immune response was predicted 
by analysis tools and T cell class I pMHC immunogenicity 
predictor at IEDB which uses amino acid properties as well as 
their position within the peptide to predict the immunogenicity 
of a class I peptide MHC (pMHC) complex [51]. 
 
CD4+ T-cell epitopes identification 
CD4+ T-cell responses against ZIKV envelope glycoprotein 
were done by using Peptide binding to MHC class II 
molecules program under MHC II binding prediction tool in 
IEDB analysis resource. For this prediction we chose seven 
abundant HLA class II alleles DRB1*01:01, DRB1*04:01, 
DRB1*07:01, DRB1*11:01 and DRB1*15:01 from the 
selection panel [52]. The predicted T-cell epitopes having 
IC50 value less than 50 were considered as potential T-cell 
epitopes and their corresponding scores for respective alleles 
were determined by PREDIVAC 
(http://predivac.biosci.uq.edu.au/cgi-bin/binding.py) [53]. 
IFN induction capacity prediction and molecular 
simulation study 
Both ZIKV envelope glycoprotein and predicted Bcell linear 
epitope (123-141) were fed to computational tool IFNepitope 
(http://crdd.osdd.net/raghava/ifnepitope/scan.php) to scan 
INF-gamma induction. This server generates all the possible 
overlapping peptides at window length of 20 and predicts IFN 
epitope in these overlapping peptides to rank these 
peptides/epitopes based on their SVM score. During scanning 
motif and SVM hybrid algorithom was applied for IFN-
gamma versus Non IFN-gamma epitopes prediction. To 
perform epitopes-receptor docking, 3D structure of the IFN-
gamma receptor alpha chain (PDB id: 1fyh) was retrieved 
from RCSB Protein Data Bank (www.rcsb.org). The protein-
protein docking of IFN-gamma receptor and ZIKV envelope 
glycoprotein was performed by PatchDock server [54] under 
default settings. The outputs of the PatchDock were fed to 
FireDock for refinement in molecular docking [55]. 
 
Results 
 
Retrieval and prediction of antigenic Protein 
The current study was originated to perform structure based 
sequence analysis of envelope glycoprotein isolated from Zika 
virus. A total of 12 polyproteins were retrieved from 
UniProtKB in FASTA format and then subjected to VaxiJen to 
predict most immunogenic protein. UniProtKB primary 
accession number Q91KX7 was predicted as the most 
antigenic one with a total score of 0.6485 at a threshold of 0.4. 
Finding of this prediction coincides with a previous finding 
where envelope glycoprotein was presented as an 
immunogenic protein [56].  
Primary and secondary structure analysis: 
Primary structure analysis revealed that the envelope protein 
(276 aa) had a molecular weight of 30.3 kD and theoretical 
isoelectric point (PI) 6.23. The total number of positively 
charged residues (Arg+Lys) and negatively charged residues 
(Asp+Glu) were 27 and 32 respectively. This finding along 
with isoelectric point indicates the protein as a negatively 
charged one.  The estimated half-life (in vitro) was 1.1 hours 
in mammalian reticulocytes. The instability index (II) was 
found 25.21, thereby categorizes the protein as a stable. The 
aliphatic index appeared as 77.72 and the N-terminus of the 
sequence showed the presence of F (Phe). The negative grand 
average of hydropathicity (GRAVY) of -0.298 denoted that 
the protein was hydrophillic. The amino acids, Leu (L), Gly 
(G), Thr (T), Ala (A) and Val (V) were found in high 
proportion in the protein. 
The secondary structure at a threshold of 8.0 from SOPMA 
was disclosed with the presence of 32 (11.59%) α-helix, 100 
(36.23%) β-sheet, 99 (35.87%) extended strand and 121 
(43.84%) coils (Fig 1) while from GOR IV had 43 (15.58%) 
α-helix, 79 (28.62%) extended strand and 154 (55.80%) coils.   
 
Figure 1: Secondary structure plot of Zika virus envelope glycoprotein (UniprotKB id: Q91KX7). Here, helix, extended 
strands and beta turns are indicated by blue, red and green respectively. 
From primary structure the GRAVY of the protein was found 
to be negative which predicts that, the most of the residues to 
be present in the surface. In addition, the aliphatic and the 
instability index of the protein described it as an aliphatic and 
stable protein respectively. The target protein also contained 
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8.3% of the threonine (T) residue, which prefers to lie in the 
beta sheet and the secondary structure analysis by SOPMA 
showed that, 36.23% region of the target protein remains as 
beta sheet. In several experiments, it was shown that the 
antigenic part of the protein is more likely to belong to the 
beta sheet region [57]. Primary and secondary structure 
analyses indicate an important feature of the target protein as 
an antigenic one. 
3D structure modeling (homology modeling) and 
validation 
From blastp it was found that template 1 had max & total 
score of 310, E-value 7e-103 and identity 50% while template 
2 had max & total score of 295, E-value 2e-97 and identity 
48%. The characteristic features for 3D structure modeling of 
desired protein by HHpred and SWISS-MODELLER are 
summarized in Table 1. 
Table 1: Characteristic features of template 1(3P54_A) and template 2 (4FG0_A) in HHpred and SWISS-MODELLER 
Templa
te 
HHpred SWISS-MODEL 
 
Coverag
e 
Zscor
e 
Seq 
id 
Confiden
ce 
Prob E 
value 
P 
value 
Score Seq 
Identity 
GMQ
E 
QMEA
N4 
3P54_A 0.981 44.29
2 
0.513 High 100.0 2E-
130 
5E-135 937.2 51.85% 0.79 -2.42 
4FG0_
A 
0.931 44.30
2 
0.506 High 100.0 5E-
129 
1E-133 929.5 49.82% 0.78 -2.27 
Post modeling analysis of the qualities of two templates 
revealed a reliable and favorable structure of both template 1 
and 2 due to similar QMEAN4 score (template 1: 0.587 and 
template 2: 0.582) but had difference in Ramachandran plots. 
Template 1 (3P54_A) at resolution 2.10 Å and R-factor of 
0.181 perceived Ramachandran plot (Psi-Phi) pairs had 305 
(87.6%) residues in most favored region [A, B,L], 41 (11.8%) 
core residues in additional allowed regions [a,b,l,p], 1 (0.3%) 
residue in generously allowed regions [~a,~b,~l,~p] and 1 
(0.3%) residue in disallowed regions [XX]. While template 2 
(4FG0_A) at resolution 3.90 Å and R-factor of 0.226 the 
perceived Ramachandran plot (Psi-Phi) pairs had 289 (87.0%)  
residues in most favored region [A, B,L], 42 (12.7%) core 
residues in additional allowed regions [a,b,l,p], 1 (0.3%) 
residue in generously allowed regions [~a,~b,~l,~p] and no 
residues in disallowed regions [XX]. These values indicated a 
good quality model of template 2 over template 1. From 
RAMPAGE it was found that, template 2 had 92.1% and 7.9% 
residues in favored and allowed region respectively while no 
residues were found in outlier region.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: (A) the 3D structure of Zika virus envelope protein. The image was retrieved from RCBS protein data bank (B) The 
Ramachandran plot for Model 2 (4FG0_A) showing residues predicted by PROCHECK and (C) RAMPAGE showing the 
residues in favored, allowed and outlier regions 
Verify3D and ERRAT were also used to further assess the 
quality of the model i.e. template 2. Verify3D analyzes the 
compatibility of the model against its own amino acid 
sequence and revealed that 95.65% of residues had an average 
3D/1D score >= 0.2 while ProSA gave the Z-score of -8.62 for 
the model. Both Verify3D and ProSA gave good scores for 
overall model quality of template 2. However the ERRAT 
validation of the model indicated the regions where the 
calculated errors were higher than expected with an overall 
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quality factor of 86.48. Subsequently, the selected model 
displayed the structure with energy minimized to 
    
                                           (C)   
Figure 3: (A) the graphical representation of ERRAT result. On the error axis two lines are drawn to indicate the confidence 
with which it is possible to reject regions that exceed that error values; (B) the Varify3D result showing 
an average 3D/1D score >= 0.2; (C) energy minimized structure and (D) Screenshot of ProSA w
Potential B cell epitope identification 
Continuous (Linear) epitope identification
Characteristic features of the B cell epitope include 
hydrophilicity, surface accessibility, and beta
Thus, several prediction methods were used to determine the 
epitope considering all these criteria. 
Kolaskar and Tongaonkar antigenicity prediction method 
functions on the basis of physiochemical properties of amino 
acids and abundances in experimentally known epitopes. The 
 et al. / Indian J. Pharm. Biol. Res., 2014; 2(4):44-57 
-6169.9509 
KB energy (kcal/mol). 
  (A) 
(B) 
         
      (D) 
(4FG0) 
 
-turn prediction. 
antigenic propensity for the protein was 1.00; all the values 
greater than 1.00 are potential antigenic determi
epitopes were found to satisfy the threshold value set prior to 
the analysis, and they have the potential to evoke the B cell 
response. The peptide from 
was found to have the highest antigenic propensity score 
(1.12). The results are summarized in 
Kolaskar and Tongaonkar antigenicity scale predicted four 
different peptides (Each seven peptide long) sequences in 
position 131-137 with maximum antigenicity score 1.186 and 
other three in positions between
136 had second highest anttigenicity score  of 1.171. BcePred 
49 
 
 
 
95.65% residues had 
eb Z-score of template 2 
nants. Sixteen 
RQTVVVLGS from 128 to 136 
Table 2 and Figure 4. 
 129-135, 128-134 and 130-
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Prediction Server predicts two possible antigenic peptide 
sequences RQTVVVLGSQ and VSYSLCT in position 
between 128-137 and 179-185 respectively at threshold 2.5. 
When all the scales from IEDB server for B cell linear epitope 
prediction were considered, sequence spanning in between 
123-141 showed highest antigenic propensity, the combined 
result illustrated in Figure 5. Analysis of the predicted peptide 
sequence with VaxiJen showed the sequence as probable 
antigen with a score of 0.73 at threshold of 0.4. Further, 
Bepipred analysis (B cell epitope prediction) revealed two 
continuous predicted epiope with 4 amino acid residues each 
in sequence positions between 124-127 and 138-141at a 
threshold of 0.350. 
 
 
Table 2: Predicted epitopes of ZIKV envelope glycoprotein via Kolaskar and Tongaonkar antigenicity scale (No. 1-16) and 
Bepipred continuous epitope prediction (No. 17-18) 
No. Start 
Position 
End 
Position 
Peptide Peptide 
Length 
Antigenic 
Propensity Score 
1 20 28 RIMLSVHGS 9 1.05 
2 42 48 KVEVTPN 7 1.04 
3 61 67 SLGLDCE 7 1.07 
4 74 80 FSDLYYL 7 1.11 
5 86 92 HWLVHKE 7 1.07 
6 95 102 HDIPLPWH 8 1.06 
7 116 122 EALVEFK 7 1.06 
8 128 136 RQTVVVLGS 9 1.12 
9 138 149 EGAVHTALAGAL 12 1.06 
10 161 170 SSGHLKCRLK 10 1.06 
11 176 197 LEGVSYSLCTAAFTFTKVPAET 22 1.07 
12 199 209 HGTVTVEVQYA 11 1.09 
13 214 222 PCKVPAQMA 9 1.09 
14 228 234 LTPVGRL 7 1.09 
15 236 243 TANPVITE 8 1.01 
16 259 270 GDSYIVIGVGDK 12 1.04 
17 124 127 AHAK 4 0.54 
18 138 141 EGAV 4 0.65 
 
 
Figure 4: Epitope prediction of ZIKV envelope glycoprotein using (A) Kolaskar andTongaonkar antigenicity prediction, (B) 
Chou & Fasman beta turn prediction, (C) Emini surface accessibility prediction, (D) Karplus and Schulz flexibility prediction, 
(E) Parker hydrophilicity prediction and (F) Bepipred linear epitope prediction 
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Figure 5: Combined B cell linear epitope prediction for ZIKV envelope glycoprotein using IEDB server showing all the scores 
for different scales and correspondent threshold value 
 
Discontinuous (Conformational) epitope identification 
3D ZIKV envelope glycoprotein was feed to ElliPro tool to 
analyze conformational epitopes for B cell. ElliPro predicted 
four distinct epitopes with residual specification and 
corresponding score which have been summarized in Table 3 
and Figure 6. The result revealed that, without any 
intervention amino acid residues for predicted linear epitope 
(123-141) overlap 78.9% of the amino acid residues for 
predicted conformational epitope with a highest score of 0.925 
at threshold of 0.80. 
Table 3: Predicted discontinuous epitopes of ZIKV envelope glycoprotein by ElliPro tools 
No. Residues Number of 
Residues 
Score 
1 _:A117, _:L118, _:V119, _:E120, _:F121, _:K122, _:D123, _:A124, _:H125, _:A126, 
_:K127, _:R128, _:Q129, _:T130, _:V131, _:V132, _:V133, _:L134, _:G135, _:S136, 
_:Q137 
21 0.925 
2 _:V223, _:D224, _:M225, _:Q226, _:T227, _:L228, _:T229, _:P230, _:P257, _:F258, 
_:G259, _:D260, _:S261, _:Y262, _:T273, _:H274, _:H275, _:W276 
18 0.854 
3 _:P47, _:N48, _:S49, _:P50, _:R51, _:D65, _:R168, _:K170 8 0.836 
4 _:V267, _:G268, _:D269, _:K270, _:K271 5 0.821 
 
                   
                                        (A)                                                                       (B) 
Figure 6: B cell discontinuous epitope predicted by ElliPro tool for ZIKV envelope glycoprotein. (A) X axis represents the 
residues number and Y axis represents the corresponding score at a threshold of 0.80. Yellow colors in the plot represent the 
polypeptide region having a score above the threshold and are likely to be potential B cell epitopes while green color reflects 
the polypeptide regions that could not satisfy the threshold margin; (B) Jmol visualization of the first of the four predicted 
epitopes. The epitope residues are in yellow while the antibody chains are white in color 
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Potential T-cell epitope identification 
 
CD8+ T-cell epitope identification 
The NetCTL prediction tool predicted 72 different epitopes 
from ZIKV envelope glycoprotein sequence according to all 
MHC (A1-B62) supertypes. But only 4 most potential epitopes 
were chosen based on their high combinatorial scores. 
To define the binding of peptides to MHC 1, SMM based 
MHC 1 binding prediction tool retrieved 196 possible MHC-1 
allele interactions with four best epitopes for T-cells. Those 
MHC-1 alleles who had higher binding affinity for each 
epitope at IC50 < 200 were selected for further analysis. 
Proteasome involves in cleaving the peptide bonds, converting 
the proteins into peptide. For that transporter of antigenic 
peptides (TAP) transfer the peptides into endoplasmic 
reticulum. After proteasomal cleavage the peptide molecules 
associated with MHC-1 and transported to cell membrane 
where they are presented to T helper cell. For T-cell epitope 
processing prediction, the total score of each epitope – HLA 
interaction was considered and higher the score meant higher 
the processing efficiency.  
Among the 4 best CD8+ T cell epitopes, a 9 mer epitope 
MMLELDPPF was found to interact with most MHC-1 alleles 
including HLA-A*02:01; HLA-A*02:06; HLA-A*23:01; 
HLA-A*29:02; HLA-A*32:01;  HLA-B*15:01; HLA-
B*15:02; HLA-B*35:01; HLA-B*53:01; HLA-C*03:03 and 
HLA-C*14:02. Then epitope MMLELDPPF was subjected to 
MHC-NP prediction tool and found that, HLA-B*53:01, 
HLA-A*02:01 and HLA-B*35:01 had highest probable score 
of 0.7516, 0.0442, and 0.0300 respectively. High probable 
score meant more likely it is naturally be processed. 
The epitope conservancy and I pMHC immunogenicity 
prediction analysis of the best epitopes showed that, all the 
three epitopes except 1 had epitope conservancy value of 
52.17% but epitope MMLELDPPF had highest I pMHC 
immunogenicity score of 0.09139. The NetCTL combined 
scores, predicted total scores with IC50 values, epitope 
conservancy and I pMHC immunogenicity prediction scores 
are summarized in Table 4.  
 
Table 4: Predicted total scores of all the processes for most potential 4 CD8+ T-cell epitopes with interacting MHC-1 alleles 
Epitope NetCTL 
combined 
score 
Interacting MHC-1 allele with an 
affinity of IC50<200 (Total score fo 
proteasome, TAP , MHC processing 
and MHC-1 binding) 
Epitope 
conservancy 
I pMHC 
immunogenicity 
prediction score 
GLDFSDLYY 
 
3.0511; A1 
0.9143; A3 
 
HLA-A*01:01; 110.8 (0.98) 
HLA-A*29:02; 35.54 (0.84) 
HLA-C*05:01; 4.25 (-0.63) 
HLA-B*15:02; 84.77 (-1.34) 
HLA-C*14:02; 57.76 (-1.6) 
HLA-C*12:03; 10.67 (-1.79) 
52.17% -0.02674 
MMLELDPPF 
 
 
1.4149; B62 
0.8398; B58 
HLA-B*15:02; 7.76 (1.17) 
HLA-B*35:01; 8.57 (1.13) 
HLA-B*15:01; 15.96 (0.86) 
HLA-A*32:01; 20.74 (0.75) 
HLA-A*02:06; 22.53 (0.71) 
HLA-B*53:01; 66.79 (0.24) 
HLA-A*02:01; 78.68 (0.17) 
HLA-A*29:02; 94.21 (0.09) 
HLA-C*03:03; 160.11 (-0.14) 
HLA-A*23:01; 167.23 (-0.16) 
HLA-C*14:02; 287.82 (-0.39) 
52.17% 0.09139 
SYSLCTAAF 1.8055; A24 
0.7502; B62 
HLA-C*14:02; 7.76 (1.5) 
HLA-A*24:02; 85.83 (1.1) 
HLA-A*23:01; 104.58 (0.92) 
HLA-C*07:02; 92.29 (0.09) 
HLA-C*12:03; 93.16 (-0.69) 
HLA-C*03:03; 59.1 (-1.39) 
52.17% -0.02494 
KLRLEGVSY 1.4556; B62 
1.1810; A3 
HLA-B*15:01; 62.66 (1.05) 
HLA-A*30:01; 137.39 (0.45) 
HLA-C*14:02; 168.9 (-0.81) 
HLA-C*12:03; 28.72 (-0.99) 
4.35% 0.07322 
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CD4+ T-cell epitope identification 
MHC class II binding prediction tool retrieved a total of 28 epitopes for HLA-DRB1*01:01; 5 epitopes for HLA-DRB1*04:01; 5 
epitopes for HLA-DRB1*07:01, 12 epitopes for HLA-DRB1*11:01 and 5 epitopes for HLA-DRB1*15:01 within IC50 less than 63. 
After analysis an epitope YRIMLSVHG was found to interact with all of the above HLA-DRB1 and can act as potential CD4+ T-cell 
epitope for ZIKV envelope glycoprotein and elicit an immune response. 
IFN epitope prediction and docking analysis 
The result from IFNepitope tool for ZIKV envelope glycoprotein and predicted B cell linear epitope revealed that, both of them had 
the probability to release of IFN-gamma with the positive score. Within entire glycoprotein position in between 124-143 
(AHAKRQTVVVLGSQEGAVHT) showed the maximum SVM score of 1.81 whereas the predicted B cell linear epitope had SVM score of 
1.29. The rigid and symmetric docking of ZIKV envelope glycoprotein with respect to the IFN-gamma was evolved by PatchDock 
algorithm and post docking refinement was done by FireDock tool. FireDock server addresses the refinement problem of protein-
protein docking solutions and simultaneously targets the problem of flexibility and scoring of solutions produced by fast rigid-body 
docking algorithms. The docking and post docking refinement results have been summarized in Table 5. The best docking pose 
ranked on global energy showed an energetically favorable interaction between ZIKV envelope glycoprotein and IFN-gamma receptor 
alpha chain (Figuer 7). 
Table 5: Docking and post docking analysis results for ZIKV envelope glycoprotein-IFN gamma receptor alpha chain 
interaction 
Rank Score Area Transformation GE Vdw 
Attractive 
Vdw 
Repulsive 
 
ACE HB 
1 12248 1748.20 1.66 0.33 -0.16 21.84 
96.41 16.81 
-44.97 -25.23 10.44 6.13 -3.41 
2 12164 2090.50 1.65 -0.98 -1.55 
36.43 56.36 1.97 
-44.79 -42.41 33.77 -3.17 -2.69 
3 11578 1465.30 -0.65 -0.26 0.40 2.42 
14.18 -75.09 
-44.55 -31.27 17.13 -5.56 -2.14 
4 14168 1836.00 2.74 -0.33 -1.21 
54.04 44.81 -52.40 
-43.30 -21.70 7.31 -5.45 -0.78 
5 12246 1764.60 -1.31 -0.30 -1.49 -
38.60 5.11 -48.42 
-42.58 -19.55 4.91 -13.12 -0.43 
6 13382 1829.80 3.10 0.38 -1.43 82.55 
72.33 68.62 
-38.68 -33.07 18.87 2.00 -4.94 
7 11404 1424.70 -0.96 -0.39 0.37 
10.85 38.56 13.54 
-38.27 -27.27 10.94 0.86 -2.11 
8 12688 1658.00 -2.16 -0.89 1.36 
76.92 112.84 -3.73 
-38.02 -25.46 22.65 -11.98 -1.64 
9 12068 1914.00 0.99 -0.66 -2.13 
37.38 43.98 -11.11 
-37.65 -27.81 9.86 1.15 -5.54 
10 12458 1979.60 1.55 -0.67 0.04 -
47.63 104.98 -79.05 
-36.97 -24.30 13.94 -7.77 -4.39 
 
The table is sorted by the global energy (GE) value while GE 
is the binding energy of a solution. Transformation refers to 
3D transformation with 3 rotational angles and 3 translational 
parameters and applied on the ligand molecule. Here Score 
means geometric shape complementary score; Area is 
approximate interface area of the complex; Vdw is Van der 
Walls; ACE means the contribution of the atomic contact 
energy (ACE) to the global binding energy and HB is the 
contribution of hydrogen bonds to global binding energy. 
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Figure 7: Best docking pose of ZIKV envelope glycoprotein with IFN-gamma receptor alpha chain. After post docking 
refinement by FireDock the best interaction was visualized by Molegro Molecula Viewer (v.2.5) 
Discussion 
The present study is a first attempt which aimed to screen new 
and highly potential immunogenic epitopes for B cell, T cell 
and IFN gamma as vaccine candidate for ZIKV envelope 
glycoprotein. Both cell mediated and humoral immunities are 
facilitated by T cell and B cell epitopes and determination of 
these epitopes are at the core of vaccine development. IFN 
gamma induced innate immune response is another important 
factor for vaccine design. To design an effective peptide 
antigen it is recommended to keep the hydrophobic amino acid 
content below 50% and peptide sequences within 8-22 amino 
acids. The continuous epitope 123  
DAHAKRQTVVVLGSQEGAV 141 for B cell was 19 amino 
acids residue long and had 42% hydrophobic amino acids 
while the discontinuous epitope 117 
ALVEFKDAHAKRQTVVVLGSQ 137  was 21 amino acids 
residue long and had 43% hydrophobic amino acids. The 
interesting finding is most of the regions for continuous 
epitope overlaps with the region of discontinuous epitope 
which discloses the residual similarities and ultimately suggest 
cross reactivity. 
Design and development of vaccine against T cell epitope is 
much more promising due to the evoke of long lasting 
immune response and antigenic drift where antigen can easily 
escape the antibody memory response [58]. Both the CD8+ 
and CD4+ T cells have vital role in antiviral immune response 
as well as antigen mediated clonal expansion of B cell. This 
study showed a range of potential epitopes for MHC class I 
and MHC class II molecules. Among the 4 most potential 
CD8+ T cell epitopes, one epitope MMLELDPPF had an 
epitope conservancy of 52.17% along with highest 
immunogenicity prediction score of 0.9139. The high level of 
epitope conservancy much more important because ZIKV has 
a higher tendency towards mutation due to the lack of 
proofreading activity of RNA polymerase [59] and 
considering a portion present in all the strains of virus is also 
recommended. Moreover the epitope MMLELDPPF showed 
interaction with HLA-A*02 which is more prevalent in Africa 
and Asia where outbreak of ZIKV has been occurred. On the 
other hand it was found that, all the CD4+ T cell epitopes were 
interact with HLA-DRB1 within IC50 less than 63 which is 
predominant in southern African population. 
Interferon Gamma (IFN-g), also called immune or type II 
interferon is a pleiotropic cytokine involved in the regulation 
of nearly all phases of immune and inflammatory responses, 
including the activation, growth and differentiation of T-cells, 
B-cells, macrophages, NK cells and other cell types such as 
endothelial cells and fibroblasts. It enhances MHC expression 
on antigen-presenting cells, and IFN- production is 
characteristic of Th1 differentiation [60]. IFN gamma 
production can be induced by ZIKV envelope glycoprotein 
and the sequences 124 AHAKRQTVVVLGSQEGAVHT 143 
showed the maximum SVM score of 1.81 and obviously 
induce the antiviral defense. 
The above findings are the result of analyzing the deposited 
data on various immune databases. The results suggest that, 
these epitopes may play a highly informative role in antidote 
production against Zika virus that can trigger an effective 
immune response in vivo. Along with in silico study, both in 
vivo and in vitro experiments are required to prove the 
effectiveness of mounting an immune response. 
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Allele Start End Peptide SMM align. Core IC50 PREDIVAC 
Score 
HLA-DRB1*01:01 16 30 NLEYRIMLSVHGSQH YRIMLSVHG 14 94.08 
HLA-DRB1*01:01 17 31 LEYRIMLSVHGSQHS YRIMLSVHG 14 94.08 
HLA-DRB1*01:01 187 201 AFTFTKVPAETLHGT FTKVPAETL 14 84.12 
HLA-DRB1*01:01 13 27 QPENLEYRIMLSVHG NLEYRIMLS 15 - 
HLA-DRB1*01:01 14 28 PENLEYRIMLSVHGS YRIMLSVHG 15 94.08 
HLA-DRB1*01:01 15 29 ENLEYRIMLSVHGSQ YRIMLSVHG 15 94.08 
HLA-DRB1*01:01 185 199 TAAFTFTKVPAETLH FTKVPAETL 15 84.12 
HLA-DRB1*01:01 186 200 AAFTFTKVPAETLHG FTKVPAETL 15 84.12 
HLA-DRB1*01:01 188 202 FTFTKVPAETLHGTV FTKVPAETL 15 84.12 
HLA-DRB1*01:01 184 198 CTAAFTFTKVPAETL CTAAFTFTK 15 - 
HLA-DRB1*11:01 13 27 QPENLEYRIMLSVHG QPENLEYRI 20 - 
HLA-DRB1*11:01 14 28 PENLEYRIMLSVHGS YRIMLSVHG 20 80.35 
HLA-DRB1*11:01 15 29 ENLEYRIMLSVHGSQ YRIMLSVHG 20 80.35 
HLA-DRB1*11:01 16 30 NLEYRIMLSVHGSQH YRIMLSVHG 20 80.35 
HLA-DRB1*11:01 17 31 LEYRIMLSVHGSQHS YRIMLSVHG 20 80.35 
HLA-DRB1*07:01 184 198 CTAAFTFTKVPAETL CTAAFTFTK 20 - 
HLA-DRB1*07:01 185 199 TAAFTFTKVPAETLH FTKVPAETL 20 80.80 
HLA-DRB1*07:01 187 201 AFTFTKVPAETLHGT FTKVPAETL 21 80.80 
HLA-DRB1*07:01 186 200 AAFTFTKVPAETLHG FTKVPAETL 22 80.80 
HLA-DRB1*07:01 188 202 FTFTKVPAETLHGTV FTKVPAETL 22 80.80 
HLA-DRB1*01:01 178 192 GVSYSLCTAAFTFTK YSLCTAAFT 32 83.93 
HLA-DRB1*01:01 177 191 EGVSYSLCTAAFTFT YSLCTAAFT 33 83.93 
HLA-DRB1*01:01 176 190 LEGVSYSLCTAAFTF YSLCTAAFT 34 83.93 
HLA-DRB1*01:01 175 189 RLEGVSYSLCTAAFT SYSLCTAAF 35 - 
HLA-DRB1*01:01 179 193 VSYSLCTAAFTFTKV YSLCTAAFT 36 83.93 
HLA-DRB1*01:01 228 242 LTPVGRLITANPVIT GRLITANPV 39 - 
HLA-DRB1*15:01 17 31 LEYRIMLSVHGSQHS YRIMLSVHG 40 81.01 
HLA-DRB1*01:01 229 243 TPVGRLITANPVITE LITANPVIT 40 81.64 
HLA-DRB1*15:01 13 27 QPENLEYRIMLSVHG ENLEYRIML 41 - 
HLA-DRB1*15:01 14 28 PENLEYRIMLSVHGS YRIMLSVHG 41 81.01 
HLA-DRB1*15:01 15 29 ENLEYRIMLSVHGSQ YRIMLSVHG 41 81.01 
HLA-DRB1*15:01 16 30 NLEYRIMLSVHGSQH YRIMLSVHG 41 81.01 
HLA-DRB1*01:01 230 244 PVGRLITANPVITES LITANPVIT 41 81.64 
HLA-DRB1*01:01 18 32 EYRIMLSVHGSQHSG YRIMLSVHG 42 94.08 
HLA-DRB1*01:01 19 33 YRIMLSVHGSQHSGM YRIMLSVHG 43 94.08 
HLA-DRB1*01:01 189 203 TFTKVPAETLHGTVT FTKVPAETL 43 82.12 
HLA-DRB1*01:01 190 204 FTKVPAETLHGTVTV FTKVPAETL 44 82.12 
HLA-DRB1*01:01 231 245 VGRLITANPVITEST LITANPVIT 49 81.64 
HLA-DRB1*01:01 138 152 EGAVHTALAGALEAE VHTALAGAL 51 - 
HLA-DRB1*01:01 137 151 QEGAVHTALAGALEA VHTALAGAL 51 - 
HLA-DRB1*01:01 139 153 GAVHTALAGALEAEM VHTALAGAL 51 - 
HLA-DRB1*01:01 136 150 SQEGAVHTALAGALE VHTALAGAL 53 - 
HLA-DRB1*01:01 232 246 GRLITANPVITESTE LITANPVIT 53 81.64 
HLA-DRB1*11:01 75 89 SDLYYLTMNNKHWLV YLTMNNKHW 56 82.65 
HLA-DRB1*11:01 76 90 DLYYLTMNNKHWLVH YLTMNNKHW 57 82.65 
HLA-DRB1*11:01 74 88 FSDLYYLTMNNKHWL YLTMNNKHW 57 82.65 
HLA-DRB1*04:01 15 29 ENLEYRIMLSVHGSQ YRIMLSVHG 60 87.88 
HLA-DRB1*04:01 16 30 NLEYRIMLSVHGSQH YRIMLSVHG 60 87.88 
HLA-DRB1*04:01 17 31 LEYRIMLSVHGSQHS YRIMLSVHG 61 87.88 
HLA-DRB1*11:01 73 87 DFSDLYYLTMNNKHW YYLTMNNKH 81 73.46 
HLA-DRB1*04:01 14 28 PENLEYRIMLSVHGS YRIMLSVHG 62 87.88 
HLA-DRB1*04:01 13 27 QPENLEYRIMLSVHG LEYRIMLSV 63 - 
HLA-DRB1*11:01 18 32 EYRIMLSVHGSQHSG YRIMLSVHG 63 87.88 
HLA-DRB1*11:01 19 33 YRIMLSVHGSQHSGM YRIMLSVHG 63 87.88 
HLA-DRB1*11:01 77 91 LYYLTMNNKHWLVHK YLTMNNKHW 63 73.46 
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